Krebs Biochemicals Hits Upper Circuit Limit Amidst Strong Trading Activity and Sector Outperformance
Krebs Biochemicals & Industries Ltd, a microcap in the Pharmaceuticals & Drugs sector, reached its upper circuit limit today, with an intraday high of Rs 74.5. The stock has gained for three consecutive days, achieving a total return of 12.1%, despite a significant decline in delivery volume.
Krebs Biochemicals & Industries Ltd, a microcap player in the Pharmaceuticals & Drugs sector, has shown significant activity today, hitting its upper circuit limit. The stock reached an intraday high of Rs 74.5, reflecting a notable increase of 4.86% during the trading session. The last traded price stands at Rs 71.05, marking an absolute change of 3.38 and a percentage change of 4.99%.The stock has been on a positive trajectory, gaining for three consecutive days and achieving a total return of 12.1% over this period. Today's performance outpaced the sector, which saw a gain of 3.59%. Despite a decline in delivery volume, which fell by 83.79% compared to the five-day average, the stock remains liquid enough for trading activities.
With a market capitalization of Rs 160.41 crore, Krebs Biochemicals & Industries continues to navigate the competitive landscape of the pharmaceuticals sector. Overall, the stock's performance today underscores its resilience and ability to attract attention in a fluctuating market environment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
